Sidney Kimmel Comprehensive Cancer Center - Johns Hopkins University School of Medicine

Baltimore, Maryland 21287

We've found

1 trials

at this facility

Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!